Global RNA Sequencing Services Markets, 2022-2035: 340+ Patents Related to RNA Sequencing have Been Recently Filed/Granted, Demonstrating the Innovation and Continuous Research Efforts in this Domain
November 25, 2022 08:48 ET
|
Research and Markets
Dublin, Nov. 25, 2022 (GLOBE NEWSWIRE) -- The "RNA Sequencing Services Market: Distribution by Type of Sequencing Method, Application Area, End User Industry and Key Geographical Regions: Industry...
Metagenomics Global Market Report 2022: Rising Demand for Effective Solutions for the Timely Diagnosis of Neuroinfectious Diseases Drives Growth
November 23, 2022 07:33 ET
|
Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Epigenetics (Reagents, Enzymes, Instruments, Kits) Market Research Report 2022: A $14.79 Billion Market in 2026 - Long-term Forecasts to 2031
November 22, 2022 06:05 ET
|
Research and Markets
Dublin, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global epigenetics market is expected to grow...
Global Pharmacogenomics Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray
November 11, 2022 06:28 ET
|
Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global pharmacogenomics market is expected...
Genomics In Cancer Care Global Market to Grow by 19.72% Annually Through 2029
November 08, 2022 06:33 ET
|
Research and Markets
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) -- The "Genomics In Cancer Care Market Analysis by Product, by Application, by Technology, End user and by Region - Global Forecast to 2029" report has been...
CRISPR and CAS Genes Global Market to Expand by 26.82% Yearly Through 2029
November 07, 2022 05:40 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "CRISPR and CAS Genes Market Analysis by Product & Service, by Application by End user, and by Region - Global Forecast to 2029" report has been...
Global Prenatal Genetic Testing Market Report 2022-2026: Technological Advancement and Low-Cost Solutions Present Opportunities
November 07, 2022 04:35 ET
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Prenatal Genetic Testing - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. New technological advances in...
Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies
October 31, 2022 09:00 ET
|
Sema4
STAMFORD, Conn., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, supports the new National Society of Genetic Counselors guidelines recommending exome...
Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns
October 27, 2022 08:00 ET
|
Sema4
-- Abnormal findings reported in 63% of infants in study, change in health management recommended in 88% of cases ---- Sema4|GeneDx contributes to latest data in the SeqFirst study being presented at...
Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels
October 26, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, has collaborated on research debunking a commonly held belief that exome and genome sequencing...